Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Xyzal® Helps Runners Rise Ready as Official Allergy Sponsor of the 2026 Boston Marathon Presented by Bank of America

Xyzal logo

News provided by

Xyzal

Mar 19, 2026, 08:02 ET

Share this article

Share toX

Share this article

Share toX

Partnership reinforces the importance of nighttime allergy relief to help you wake up refreshed and ready for a productive day ahead

MORRISTOWN, N.J., March 19, 2026 /PRNewswire/ -- Xyzal®, an Opella brand and leading allergy brand, becomes the first official allergy sponsor of the 2026 Boston Marathon presented by Bank of America to reinforce a simple but powerful idea: "Allergy relief tonight. Rise ready tomorrow."

Continue Reading
Boston Marathon
Boston Marathon
Becs Gentry
Becs Gentry
Xyzal Allergy 24HR
Xyzal Allergy 24HR

Xyzal® knows that marathon training demands consistency and commitment, especially during peak allergy season. About one in four athletes suffer from allergies1, and those symptoms are closely linked to sleep disruption2 - reducing sleep quality and limiting the restorative sleep needed for optimal performance. As the only allergy medicine designed to be taken at night3, Xyzal® is emphasizing the importance of relieving allergy symptoms at night to help allergy sufferers Rise Ready to train and make the most of their day. With the power of 24-hour relief that won't fade, Xyzal® starts working at night to help relieve allergy symptoms during sleep, helping allergy sufferers wake up refreshed and ready for a more productive day.

"Every year, the Boston Marathon brings together athletes who have spent months preparing for their moment," said Jack Fleming, President and CEO of the Boston Athletic Association, organizer of the Boston Marathon. "Xyzal's focus on helping people wake up ready for the day ahead aligns well with the dedication and preparation that defines the marathon experience."

As part of this year's Boston Marathon sponsorship, Xyzal® will be on-site throughout marathon weekend with an interactive presence at the Bank of America Boston Marathon Expo from Friday, April 17 through Sunday, April 19. Runners and fans are invited to stop by the Xyzal® booth to meet Xyzal® spokesperson and Peloton® instructor Becs Gentry, who will be on-site to share her perspective as a marathon and ultramarathon runner who trains and competes while managing seasonal allergies. Visitors can also explore nighttime‑themed booth elements designed to underscore the importance of relieving allergy symptoms while you sleep, enjoy complimentary samples of Xyzal® Allergy 24HR, pick up branded merchandise, snap photos, and interact with Xyzal's iconic mascot, Nigel the Owl. Coupled with the Expo presence, race spectators on Monday, April 20, can cheer on "Nigel's Flock," a group of 10 influencer runners sponsored by Xyzal® to showcase the power of running at your best—even during allergy season.

"As both an endurance athlete and someone who suffers from seasonal allergies, I know how disruptive allergy season can be in everyday life, let alone to a training routine," said Gentry. "Staying consistent with training routines can be more challenging during allergy season, especially when symptoms disrupt sleep. Relieving my allergies, especially overnight, helps me feel ready to take on the next day, whether I'm training, running or teaching."

Follow along on social media for stories from the runners, allergy tips, and a marathon recap. For more information about Xyzal®, follow Xyzal® on TikTok or Instagram and visit www.Xyzal.com.

About Opella

Opella is a global consumer healthcare company headquartered in Paris, France, specializing in over‑the‑counter medicines and self‑care products. Established in 2024, Opella operates in 43 countries and distributes its portfolio—featuring well‑known brands such as Allegra, Doliprane, Mucosolvan, Buscopan and Xyzal®—to consumers in more than 140 markets worldwide. With approximately 11,000 employees, Opella is committed to making self‑care simple and accessible, supported by strong ethical practices and B Corp certifications across several regions.

About Xyzal®

Xyzal® is an oral, over‑the‑counter antihistamine from Opella that provides 24‑hour relief from allergy symptoms. Its active ingredient, levocetirizine dihydrochloride, starts working in as little as 45 minutes and helps relieve symptoms caused by both outdoor allergens (pollen, ragweed, grass, and trees) and indoor allergens (dust, mold, and pet dander). Designed to be taken at night, Xyzal® helps relieve allergy symptoms while you sleep so you can wake up feeling refreshed and ready for the day.

ABOUT THE BOSTON ATHLETIC ASSOCIATION (B.A.A.)

Established in 1887, the Boston Athletic Association is a non-profit organization with a mission of promoting a healthy lifestyle through sports, especially running. The B.A.A. manages the Boston Marathon presented by Bank of America, and supports comprehensive charity, youth, and year-round programming. The 130th Boston Marathon presented by Bank of America is scheduled to take place on Monday, April 20, 2026.

The Boston Marathon is part of the Abbott World Marathon Majors, along with international marathons in Tokyo, London, Sydney, Berlin, Chicago, and New York City. For more information on the B.A.A., please visit www.baa.org.

References

1Bonini, Matteo; Gramiccioni, Claudia; Fioretti, Daniela; Ruckert, Beate; Rinaldi, Monica; Akdis, Cezmi; Todaro, Antonio; Palange, Paolo; Carlsen, Kai-Hakon; Pelliccia, Antonio; Rasi, Guido; Bonini, Sergio on behalf of the AIDA and the Italian Unit of the GA2LEN Olympic Study. Asthma, allergy and the Olympics: a 12-year survey in elite athletes. Current Opinion in Allergy and Clinical Immunology 15(2):p 184-192, April 2015. | DOI: 10.1097/ACI.0000000000000149 https://journals.lww.com/co-allergy/abstract/2015/04000/asthma,_allergy_and_the_olympics__a_12_year_survey.13.aspx
2
Weaver-Agostoni J, Kosak Z, Bartlett S. Allergic Rhinitis: Rapid Evidence Review. Am Fam Physician. 2023;107(5):466-473. https://www.aafp.org/pubs/afp/issues/2023/0500/allergic-rhinitis.html
3
Disclaimer: BENADRYL® dosing guide: Adult & Children's Diphenhydramine Dosage. ZYRTEC®
Allergy Relief Tables with 10 mg Cetirizine. CLARITIN® Tablets 24-Hour- Relieve Allergy Symptoms

Media contact: Nyaa Ferary, [email protected]

SOURCE Xyzal

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.